Advertisement
Research Article

Is the Prevalence of Overactive Bladder Overestimated? A Population-Based Study in Finland

  • Kari A.O. Tikkinen mail,

    To whom correspondence should be addressed. E-mail: kari.tikkinen@fimnet.fi

    Affiliations: Department of Urology, Tampere University Hospital, Tampere, Finland, Medical School, University of Tampere, Tampere, Finland, Tampere School of Public Health, University of Tampere, Tampere, Finland

    X
  • Teuvo L.J. Tammela,

    Affiliations: Department of Urology, Tampere University Hospital, Tampere, Finland, Medical School, University of Tampere, Tampere, Finland

    X
  • Aila M. Rissanen,

    Affiliation: Obesity Research Unit, Helsinki University Central Hospital, Helsinki, Finland

    X
  • Antti Valpas,

    Affiliation: Department of Obstetrics and Gynecology, South Karelian Central Hospital, Lappeenranta, Finland

    X
  • Heini Huhtala,

    Affiliation: Tampere School of Public Health, University of Tampere, Tampere, Finland

    X
  • Anssi Auvinen

    Affiliation: Tampere School of Public Health, University of Tampere, Tampere, Finland

    X
  • Published: February 07, 2007
  • DOI: 10.1371/journal.pone.0000195

About the Authors

Kari A.O. Tikkinen, Teuvo L.J. Tammela
Department of Urology, Tampere University Hospital, Tampere, Finland
Kari A.O. Tikkinen, Teuvo L.J. Tammela
Medical School, University of Tampere, Tampere, Finland
Kari A.O. Tikkinen, Heini Huhtala, Anssi Auvinen
Tampere School of Public Health, University of Tampere, Tampere, Finland
Aila M. Rissanen
Obesity Research Unit, Helsinki University Central Hospital, Helsinki, Finland
Antti Valpas
Department of Obstetrics and Gynecology, South Karelian Central Hospital, Lappeenranta, Finland

Corresponding Author

Email: kari.tikkinen@fimnet.fi

Competing Interests

Aila Rissanen, Heini Huhtala, and Anssi Auvinen declare no conflict of interest, whereas Kari Tikkinen declares honorarium for Pfizer, Teuvo Tammela consultancies and honoraria for Pfizer, UCB and Astellas Pharma, and Antti Valpas consultanties for Pfizer and honoraria for Astellas Pharma.

Author Contributions

Other: Designed the study: KT TT AA. Peformed further statistical analyses: KT HH AA. Contributed to the interpretation of the findings and formulation of the report: KT TT AR AV HH AA. Wrote the first draft of the manuscript: KT. Contributed to revision of the manuscript: KT TT AR AV HH AA.